Scenario Cliff Crandall, Senior Director of Supply Chain for Young Again Pharmaceuticals (YAP) is gearing up for a critical product roll-out. YAP is a bio-tech research firm that focuses on natural remedies and was an early adopter of sustainability as a core company value. The company has developed a breakthrough liquid suspension that reverses the ageing process for anyone over 35 years of age. The new product has been dubbed Twenty- something in a Bottle or TSB by the media. Demand is expected to be very high despite the price tag of $395 for one bottle (a months supply). TSB will be supplied by a contract drug manufacturer, though the specific vendor has not been chosen yet. Given that the product is applied to the skin, product purity and quality are critically important.

1. Based on the case information and your analysis, which supplier would you choose? Why?